Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Von Willebrand factor A domain-containing protein 7 (VWA7) is a poorly characterized human protein encoded by the VWA7 gene (aliases C6orf27, G7C, NG37)[2]. It contains a von Willebrand factor type A (vWA) domain, a structural motif found in many proteins, most notably von Willebrand factor itself, integrins, and collagens[2][4]. VWA domains are involved in protein-protein interactions essential for cell adhesion and extracellular matrix function, and may bind metal ions at sites known as MIDAS motifs[2][4]. However, the specific biological function of VWA7 and its role in health or disease are currently unknown. It is not recognized as a therapeutic target, diagnostic biomarker, or drug-interacting protein as of this writing[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Von Willebrand factor A domain-containing protein 7 (VWA7).